Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Industry Landscape

Articles under this category focus on macro trends, big pharma behavior, and annual outlooks.

Email Segmentation in Pharma Campaigns: Precision, Compliance, and the Next Frontier of Patient and HCP Engagement
Posted in
  • Industry Landscape

Email Segmentation in Pharma Campaigns: Precision, Compliance, and the Next Frontier of Patient and HCP Engagement

Pharmaceutical marketers face a dual mandate: deliver clinically relevant information while meeting strict regulatory obligations. Email … Email Segmentation in Pharma Campaigns: Precision, Compliance, and the Next Frontier of Patient and HCP EngagementRead more

by Ritu Negi•February 7, 2026February 7, 2026•0
Why Patient Recruitment Is the Biggest Problem in Clinical Trials Today
Posted in
  • Digital Transformation
  • Industry Landscape

Why Patient Recruitment Is the Biggest Problem in Clinical Trials Today

Patient recruitment remains the single most persistent bottleneck in clinical trials today. Despite advances in trial … Why Patient Recruitment Is the Biggest Problem in Clinical Trials TodayRead more

by Jayshree Gondane•February 6, 2026February 6, 2026•0
How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical Market
Posted in
  • Industry Landscape
  • Strategy & Execution

How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical Market

In the United States, drug approval timelines are becoming harder to predict. Despite record investment in … How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical MarketRead more

by Jayshree Gondane•February 6, 2026February 6, 2026•0
Why Great Science Often Fails Commercially in Pharma
Posted in
  • Industry Landscape
  • Strategy & Execution

Why Great Science Often Fails Commercially in Pharma

In the United States, bringing a new drug to market now costs more than $2 billion on average … Why Great Science Often Fails Commercially in PharmaRead more

by Jayshree Gondane•February 6, 2026February 6, 2026•0
Social Proof in Pharma Marketing: Evidence, Ethics, and Industry Impact
Posted in
  • Industry Landscape

Social Proof in Pharma Marketing: Evidence, Ethics, and Industry Impact

Pharmaceutical marketing has shifted rapidly from physician-centric promotion to a complex ecosystem that includes patients, caregivers, … Social Proof in Pharma Marketing: Evidence, Ethics, and Industry ImpactRead more

by Ritu Negi•February 6, 2026February 6, 2026•0
Pharma Marketing for Vaccines: Strategy, Regulation, and Evidence-Driven Engagement
Posted in
  • Industry Landscape

Pharma Marketing for Vaccines: Strategy, Regulation, and Evidence-Driven Engagement

Introduction: A Unique Marketing Landscape Pharmaceutical marketing for vaccines operates at the intersection of public health, … Pharma Marketing for Vaccines: Strategy, Regulation, and Evidence-Driven EngagementRead more

by Ritu Negi•February 6, 2026February 6, 2026•0
Pharmaceutical PR Campaign Examples: Data-Driven Strategies
Posted in
  • Industry Landscape

Pharmaceutical PR Campaign Examples: Data-Driven Strategies

Pharmaceutical public relations (PR) campaigns operate at the intersection of healthcare, public trust, regulatory scrutiny, and … Pharmaceutical PR Campaign Examples: Data-Driven StrategiesRead more

by Ritu Negi•February 6, 2026February 6, 2026•0
Pharma Marketing in Emerging Markets: Navigating Growth, Regulation, and Digital Transformation
Posted in
  • Industry Landscape

Pharma Marketing in Emerging Markets: Navigating Growth, Regulation, and Digital Transformation

Introduction: Why Emerging Markets Now Drive Pharma’s Growth Agenda The pharmaceutical industry has entered a pivotal … Pharma Marketing in Emerging Markets: Navigating Growth, Regulation, and Digital TransformationRead more

by Ritu Negi•February 6, 2026February 6, 2026•0
Loyalty Apps for Pharma Customers: Strategic Value, Regulatory Realities and the Future of Patient Engagement
Posted in
  • Industry Landscape

Loyalty Apps for Pharma Customers: Strategic Value, Regulatory Realities and the Future of Patient Engagement

Introduction: The Shift Toward Experience-Driven Pharma Engagement Pharmaceutical companies have entered a new competitive phase defined … Loyalty Apps for Pharma Customers: Strategic Value, Regulatory Realities and the Future of Patient EngagementRead more

by Ritu Negi•February 6, 2026February 6, 2026•0
Pharmaceutical E-commerce Strategies
Posted in
  • Industry Landscape

Pharmaceutical E-commerce Strategies

Introduction: The Rapid Institutionalization of Pharma E-commerce Pharmaceutical e-commerce has transitioned from a niche convenience service … Pharmaceutical E-commerce StrategiesRead more

by Ritu Negi•February 5, 2026February 5, 2026•0

Posts pagination

1 2 … 12 Next

Recent Posts

  • Pharma Marketing Analytics Dashboards: Data-Driven Strategy in a Regulated Industry
  • Email Segmentation in Pharma Campaigns: Precision, Compliance, and the Next Frontier of Patient and HCP Engagement
  • Pharmaceutical Partnership Marketing
  • Interactive Quizzes for Patient Awareness in Pharmaceutical Marketing
  • Why Patient Recruitment Is the Biggest Problem in Clinical Trials Today

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A